Cilostazol
Product Images NDC 16590-285

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 16590-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cilostazol 100mg Label Image (Cilostazol 100mg Label)

FDA Label Image
FDA Label Image

Chemical Structure (Chem Structure)

Chemical Structure (Chem Structure)
The text is not-available.*
FDA Label Image

Graph (Graph 1)

Graph (Graph 1)
This appears to be a table displaying plasma concentration levels of three different forms of a drug called Cilostazol over time. The forms of the drug are listed as 1600, 3,4-dehydro-cilostazol, and 4-trans-hydroxy-cilostazol. The X-axis represents time in hours and the Y-axis represents plasma concentration measured in ng/mL. There is not enough information provided to draw any specific conclusions or insights from this table.*
FDA Label Image

Graph 2 (Graph 2)

Graph 2 (Graph 2)
Percent Mean Improvement in Maximal Walking Distance for randomized, double-blind, placebo-controlled clinical trials, measuring the effectiveness of Cilostazol at 50mg and 100mg bid. The study had eight trials of varying duration, one lasting 12 weeks and another lasting 416 weeks. The table in the source document displays the percentage mean improvement in maximal walking distance for the study.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.